download 2026 03 25T200618.431
|

Breakthrough for ‘neglected’ rheumatic disease

Scientists have had success treating a ‘neglected’ inflammatory disease, polymyalgia rheumatica, with a drug that could offer patients an alternative to steroids.

The study, conducted by Anglia Ruskin University (ARU) and published in the New England Journal of Medicine, describes a successful trial of sarilumab. The drug, approved in Britain to treat rheumatoid arthritis, blocked the protein interleukin-6, which can cause inflammation.

Polymyalgia rheumatica (PMR) is characterized by pain and morning stiffness in the shoulder and hips and affects people over the age of 50. It can significantly affect quality of life and is currently mainly treated with the steroid glucocorticoids.

Although glucocorticoids can control the condition, more than half of PMR patients experience a relapse of their condition when they reduce their steroid medication. Interleukin-6 has been implicated in the pathophysiology of PMR because circulating elevated levels and increased tissue expression of interleukin-6 have been found in PMR patients.

During the year-long clinical trial conducted by researchers, 118 patients received either twice-monthly injections of sarilumab or a placebo. The sarilumab group received a tapering dose of glucocorticoid for 14 weeks in combination with bimonthly injections of sarilumab, while the placebo group received a tapering dose of glucocorticoid for 52 weeks.

The primary outcome at the end of the study was sustained remission of the condition. This happened in 28% of people taking sarilumab, compared to 10% of people taking the placebo. After achieving remission at 12 weeks, there were more disease flares in the placebo group (57%) compared to those who received sarilumab (24%).

Lead PMR expert and senior author of the study, Professor Bhaskar Dasgupta, from Anglia Ruskin University’s Medical Technology Research Center (ARU), said: “Polymyalgia rheumatica is a poorly managed and neglected condition for which current treatment is unsatisfactory and long time can take. Long-term side effects: Patients may experience relapses while tapering their medications, and very limited treatment options currently exist for these relapses.

“Our findings show promise that sarilumab can be used to treat PMR and improve outcomes for people coming off steroid medications.

“This is an exciting development that has the potential to improve treatment options for a condition common in older people. PMR is the most common reason for long-term steroid prescriptions. Any effective drug that can spare the use of steroids would be a should have a major impact.” on reducing the serious side effects of such steroids, including diabetes, osteoporotic fractures and infections.”

The research was funded by Sanofi and Regeneron Pharmaceuticals.

Source link

Similar Posts

  • Regular football training improves lung diffusion capacity in boys aged 6 to 10 years | BMC Sports sciences, medicine and rehabilitation

      Attendees The required sample size was calculated using G*Power (version 3.1, University of Düsseldorf, Germany) [21]. The a priori power analysis was calculated with an assumed power of 0.90, an alpha level of 0.01 and an effect size of Cohen’s f = 0.26 for pulmonary diffusion capacity (TL) [10]. The analysis showed that a…

  • Knee Osteoarthritis & Whole Body Pain Relief

    Welcome to our comprehensive guide on knee osteoarthritis and how to find relief from whole body pain caused by this common condition. If you or a loved one is suffering from knee osteoarthritis, you know firsthand the debilitating effects it can have on everyday life. From the constant discomfort and limited mobility to the impact…

  • |

    POLARIS AR receives US Food and Drug Administration approval for STELLAR Knee

      MIAMI, Nov. 3, 2023 /PRNewswire/ — POLARISAR is pleased to announce today that their STELLAR knee has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). STELLAR Knee is the first approval for POLARISARa company focused on creating a new category in surgical guidance in Mixed Reality. POLARISAR and STELLAR Knee are…

  • Best ice machine for knee surgery (Game Ready, Polar Care)

    What if you could recover from knee surgery with less pain and fewer medications? This question is at the heart of modern post-operative care. Managing discomfort and swelling is a major challenge after an orthopedic procedure. cold therapy system Cold therapy offers a powerful, drug-free solution. It is a non-invasive method to control inflammation and pain directly at the source. Specialized units deliver consistent cooling to the affected area. This can significantly reduce the need for strong painkillers during the critical healing phase. We have thoroughly examined the market of recovery tools. Our guide focuses on leading systems, including various Breg Polar Care models and the Game Ready unit. Our goal is to help you navigate your options. You can find a system that fits your needs and supports a smoother, more comfortable recovery at home. Key Takeaways Cold therapy is a proven, drug-free method to manage pain and swelling after surgery. Using a dedicated cooling unit can help reduce reliance on narcotic pain medication. Popular systems like the Breg Polar Care line come in several models, such as the Cube, Kodiak, Glacier, and Wave. Game Ready is a leading unit that combines cold therapy with adjustable compression. Always consult your healthcare provider to ensure this therapy is right for your specific procedure. Selecting the right device involves considering your budget and recovery goals. Effective, consistent cooling can greatly improve comfort and outcomes during the healing process. Introduction to Knee Surgery Recovery and Cold Therapy Successfully navigating the first weeks post-surgery hinges on a structured recovery strategy. This plan must prioritize managing two key issues: discomfort and inflammation. This is where cold therapy, also called cryotherapy, becomes essential. It involves applying controlled cooling to the surgical area to reduce inflammation. After a procedure, fluid often accumulates in the joint. This swelling, known as edema, increases pressure and causes significant pain. The therapy works by constricting blood vessels. This action helps limit the amount of fluid and blood pooling at the injury site. Many surgeons now recommend a dedicated cooling device. These units provide consistent, targeted cold therapy that is far more effective than basic ice packs. Reducing swelling early is crucial. It directly supports efforts to regain a full range of motion in the knee during rehabilitation. Healthcare providers often prescribe this therapy as a safe alternative to stronger pain medications. Patients should always combine its use with specific exercise advice from a physiotherapist. This promotes healthy blood flow and ensures optimal healing. How Cold Therapy Works in Reducing Swelling and Pain Cold therapy targets the root causes of post-operative discomfort through a simple yet powerful process. It directly addresses the inflammation and pain that hinder healing. Mechanism of Action in Cold Therapy The primary mechanism involves using cold water to constrict blood vessels. This reduces blood flow and inflammation in the affected area. A dedicated unit provides a continuous, even distribution of this chilled liquid. It maintains a steady cold temperature for many hours. cold therapy mechanism Advantages Over Traditional Ice Packs Basic ice packs warm up quickly due to body heat. Their effectiveness diminishes within minutes. In contrast, a motorized therapy system eliminates frequent trips to the freezer. Its large, insulated reservoir ensures prolonged cooling. Specialized pads are designed for specific body parts. They deliver targeted cold therapy exactly where needed. This approach prevents the condensation issues of melting ice packs. It keeps the surgical site clean and dry, enhancing comfort and hygiene. Overview of Cold Therapy Devices for Post-Surgical Recovery The market offers two primary types of cold therapy units, each with distinct mechanisms and benefits. Selecting the right one depends on your mobility, budget, and recovery goals. We categorize these devices into gravity-fed and motorized systems. This helps you understand which technology best suits your specific needs. Types of Devices: Motorized and Gravity-Fed Systems Gravity-fed devices, like the Aircast Cryo/Cuff, use elevation to circulate water without a motor. They are cost-effective and portable. The simple physics of elevation moves chilled liquid through the pad. Motorized systems provide constant recirculation of cold water between a cooler and the pad. This is ideal for patients with limited mobility after a procedure. Brands like Breg Polar Care circulate water directly for efficient cooling. The DonJoy IceMan series uses dual pump technology for a comfortable temperature. Some advanced therapy units, such as the Ossur Cold Rush, feature an adjustable flow dial. This allows patients to customize their experience. Understanding these mechanical differences is key before making a purchase. Both types deliver effective cold therapy, but their operation varies. Key Features to Consider When Purchasing an Ice Machine Several practical factors determine how well a cold therapy machine will serve you at home. The right features enhance both effectiveness and convenience during your healing period. Consistency, Coverage, and Temperature Control Look for a unit that maintains a steady cold temperature. Consistent cooling is vital for safe, prolonged sessions. Good coverage means the pad fits your joint properly. This ensures the therapy reaches all affected areas. Adjustable controls let you fine-tune the intensity. This prevents skin irritation while maximizing comfort. cold therapy…

  • John Booth retires as CEO of Spineology Inc.

      Brian Snider appointed new CEO SAINT PAUL, Minn., November 9, 2023–(BUSINESS WIRE)–Spineology Inc. (“Spineology” or the “Company”), the leader in ultra-minimally invasive spine surgery, today announced that John Booth will resign from his position as Chief Executive Officer of Spineology, effective November 10, 2023. The Board of Directors has selected Brian Snider as the…

  • |

    Epidemiology and clinical features of interstitial lung disease in patients with rheumatoid arthritis from the JointMan database

      Data source Patient demographics and disease characteristics were retrospectively analyzed after data extraction from the Discus Analytics JointMan database, a large US electronic health record-based dataset initiated in March 2009. The JointMan database includes > 17,000 rheumatology patients covered by commercial, Medicare, or Medicaid insurance. plan. Practices in the following eight states are included:…

Leave a Reply

Your email address will not be published. Required fields are marked *